Symbols

PLSE

Pulse Biosciences·NASDAQ

--(--)

PLSE Profile

Pulse Biosciences, Inc.

A novel bioelectric medicine company that develops medical devices based on a nano-pulse electro signaing platform for the treatment of tumors

Industry

Healthcare Equipment and Supplies

Established Date

05/19/2014

Listing Date

05/18/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

116

Fiscal Year Ends

12-31

Website

www.pulsebiosciences.com

Security Type

Common stock

Office address

601 Brickell Key Drive, Suite 1080, Miami, FL 33131

Business

Introduction

Pulse Biosciences, Inc. was originally incorporated in Nevada on May 19, 2014. Effective June 18, 2018, the Company was re-registered as a Delaware corporation. The Company is a novel ablation company dedicated to healthy innovations using its patented Nano-Pulse Stimulation (" NPS ") technology, a revolutionary energy mode that delivers electrical pulses of nanosecond duration, each of which is less than one millionth of a second in length, to remove or kill target cells in a non-thermal manner. NPS technology, also known as nanosecond pulse field ablation (" nsPFA ") technology, when used to ablate cellular tissue, can be used to treat a variety of diseases for which no optimal solution has been found.